As of 4:00pm ET
| +0.11 / +1.20%|
The 4 analysts offering 12-month price forecasts for Veracyte Inc have a median target of 12.50, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +34.41% increase from the last price of 9.30.
The current consensus among 5 polled investment analysts is to Buy stock in Veracyte Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.